October 2014 | R. Magee | APS-DPP | Poster
Neutral beam injected fast ions play a critical role in the C-2 field reversed configuration plasma, helping to sustain magnetic flux against resistive decay and heating the plasma via Coulomb collisions.
October 2014 | A. Necas | APS-DPP | Poster
In standard C-2 Field Reversed Configuration plasmas, a toroidal current is driven in deuterium plasma with hydrogen neutral beam injection.
October 2014 | S. Gupta | APS-DPP | Poster
Recently, improved high confinement regime is observed in C2 FRC plasma due to better wall conditions and higher formation magnetic field.
October 2014 | P. Yushmanov | APS-DPP | Poster
Increasing understanding of electron dynamics in large expander ratio FRC diverter by analytic and numerical models.
October 2014 | I. Vinyar | Instruments and Experimental Techniques | Paper
A compact 12-barrel deuterium pellet injector for plasma studies in the C-2 field-reversed configuration device (USA) is described.
October 2014 | H.U. Rahman | IEEE Transactions on Plasma Science | Paper
A standard magnetohydrodynamic code, MACH2 [1], is modified in 1-D to account for two-fluid behavior, to include the effects of a finite-electric field during the formation of a driven, field-reversed configuration (FRC).
September 2014 | M. Tuszewski | PPPL Colloquium | Presentation
Hybrid FRCs successfully produced in C-2 device. HPF breakthrough. Improved FRC stability and confinement. FRC sustainment techniques developed.
September 2014 | A. Ivanov | Proceedings of NIBS | Paper
The negative-ion based injector of a hydrogen neutral beam with the energy of 500- 1000 keV is being developed in the Budker Institute.
August 2014 | L. Steinhauer | Physics of Plasmas | Paper
An interpretive method is developed for extracting details of the fully two-dimensional (2D) “internal” structure of field-reversed configurations (FRC) from common diagnostics.
August 2014 | H. Gota | 2014 Open Systems | Presentation
High-temperature, stable, long-lived FRC state called, High Performance FRC (HPF), has been produced in the C-2 device with plasma-guns and NB injections.